Hepatopulmonary syndrome: Favorable outcomes in the MELD exception era

Hepatology

Volumn 57, Issue 6, 2013, Pages 2427-2435

  Iyer, Vivek N ^a   Swanson, Karen L ^a   Cartin Ceba, Rodrigo ^a   Dierkhising, Ross A ^a   Rosen, Charles B ^a   Heimbach, Julie K ^a   Wiesner, Russell H ^a   Krowka, Michael J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; MACROSALB TC 99M;

ADOLESCENT; ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BRAIN SCINTISCANNING; CHILD; DISEASE SEVERITY; FEMALE; FLUID BALANCE; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; LUNG FUNCTION TEST; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORBIDITY; MORTALITY; OVERALL SURVIVAL; OXYGENATION; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANOXIA; CEREBROVASCULAR CIRCULATION; CHILD; FEMALE; FOLLOW-UP STUDIES; HEPATOPULMONARY SYNDROME; HUMANS; LIVER TRANSPLANTATION; LUNG; MALE; MIDDLE AGED; MINNESOTA; PULMONARY CIRCULATION; SEVERITY OF ILLNESS INDEX; TECHNETIUM TC 99M AGGREGATED ALBUMIN; YOUNG ADULT;

EID: 84879121783     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26070     Document Type: Article

References (21)

1. Rodiguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome: a liver-induced lung vascular syndrome. N Engl J Med 2008; 358: 2378-2387.
2. Fallon MB, Mulligan DC, Gish RG, Krowka MJ. Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome. Liver Transpl 2006; 12: S105-S107.
3. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. HEPATOLOGY 2005; 41: 1122-1129.
4. Dafni U. Landmark analysis at the 25-year landmark point. Circ Cardiovasc Qual Outcomes 2011; 4: 363-371.
5. Scott V, Miro A, Kang Y, DeWolf A, Bellary S, Martin M, et al. Reversibility of hepatopulmonary syndrome by orthotopic liver transplantation. Transpl Proc 1993; 25: 1787-1788.
6. Hobieka J, Houssin D, Bernard O, Devictor D, Grimon G, Chapius Y. Orthotopic liver transplantation in children with chronic liver disease and severe hypoxemia. Transplantation 1994; 57: 224-228.
7. Fewtrell MS, Noble-Johnson G, Revell S, Valente J, Friend P, Johnston P, et al. Intrapulmonary shunting in the biliary atresia/polysplenia syndrome: reversal after liver transplantation. Arch Dis Child 1994; 70: 501-504.
8. Barbe T, Losay J, Grimon G, Devictor D. Sardet A. Gauthier F, et al. Pulmonary arteriovenous shunting in children with liver disease. J Pediatr 1995; 126: 571-579.
9. Egawa H, Kasahara M, Inomata Y, Uemoto S, Asonuma K, Fufita S, et al. Long-term outcome of living-related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation 1999; 67: 712-717.
10. Collisson EA, Nourmand H, Fraimann MH, Cooper CB, Bellamy PE, Farmer DG, et al. Retrospective analysis of results of liver transplantation for adults with severe portopulmonary hypertension. Liver Transpl 2002; 8: 925-931.
11. Taille C, Cadranel J, Bellocq A, Thabut G, Soubrane O, Durand F, Ichai P, et al. Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation 2003; 75: 1482-1489.
12. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. HEPATOLOGY 2003; 37: 192-197.
13. Schenk P, Schoniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003; 125: 1042-1052.
14. Kim HY, Chois MS, Lee SC, Park SW, Lee JH, Koh KC, et al. Outcomes in patients with hepatopulmonary syndrome undergoing liver transplantation. Transplant Proc 2004; 36: 2762-2763.
15. Krowka MJ, Mandell SM, Ramsay MAE, Kawut SM, Fallon MB, Manzarbeitia C, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004; 10: 174-182.
16. Schiffer E, Majno P, Mentha G, Giostra E, Burri H, Klopfenstein CE, et al. Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: a prospective study in 90 patients. Am J Transplant 2006; 6: 1430-1437.
17. Deberaldini M, Arcanjo ABB, Melo E, da Silva RF, Felicio HCC, Arroyo PC, et al. Hepatopulmonary syndrome: morbidity and survival after liver transplantation. Trans Proc 2008; 40: 3512-3516.
18. Gupta S, Castel H, Rao RV, Picard M, Lilly L, Faughnan ME, et al. Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transplant 2010; 10: 354-363.
19. Sulieman BM, Hunsicker LG, Katz DA, Voight MD. OPTN policy regarding prioritization of patients with hepatopulmonary syndrome: does it provide equitable organ allocation? Am J Transplant 2008; 8: 954-964.
20. Krowka MJ, Fallon MB. Liver transplantation for hepatopulmonary syndrome (HPS): what is the MESSAGE? Am J Transplant 2008; 8: 911-912.
21. O'Grady JG, Wendon J. Pushing the boundaries in hepatopulmonary syndrome. Am J Transplant 2010; 10: 203-204.